Pharmacotherapy of persistent genital arousal disorder/genito-pelvic dysesthesia: an updated review and data from a registry

Tillmann H. C. Kruger,Sophie Köhne,Franziska M. L. M. Kümpers
DOI: https://doi.org/10.1080/14656566.2024.2415696
2024-10-25
Expert Opinion on Pharmacotherapy
Abstract:Introduction Persistent genital arousal disorder/genitopelvic dysesthesia (PGAD/GPD) is a rare, yet debilitating disease, which has been included in ICD-11. Pharmacotherapy in PGAD/GPD is a mixed blessing – drugs may either alleviate symptoms or worsen/induce them. Therefore, we aim at offering both an overview of pharmacological approaches to treat this disorder, including treatment failures, and to highlight drugs that may induce or worsen symptoms. We include all available data published so far as well as data from an own registry.
pharmacology & pharmacy
What problem does this paper attempt to address?